On the public citation graph
Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
0 signed · 125 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
1 of the 38 references listed on this page is in the Retraction Watch database as retracted (export 2026-10-28): 10.1056/nejmoa2007621 (notice 2020-06-04).
Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2020.4683openalex-snapshot
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
inferredcites →https://doi.org/10.1001/jama.2020.4812openalex-snapshot
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
inferredcites →https://doi.org/10.1001/jamacardio.2020.1282openalex-snapshot
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers
inferredcites →https://doi.org/10.1001/jamacardio.2020.1624openalex-snapshot
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
inferredcites →https://doi.org/10.1001/jamacardio.2020.1855openalex-snapshot
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
inferredcites →https://doi.org/10.1016/j.bbrc.2003.11.054openalex-snapshot
The SARS-CoV S glycoprotein: expression and functional characterization
inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
inferredcites →https://doi.org/10.1016/j.phrs.2017.06.005openalex-snapshot
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
inferredcites →https://doi.org/10.1016/s2213-2600(20)30079-5openalex-snapshot
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
inferredcites →https://doi.org/10.1016/s2213-2600(20)30116-8openalex-snapshot
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
inferredcites →https://doi.org/10.1038/nature02145openalex-snapshot
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
inferredcites →https://doi.org/10.1038/nm1267openalex-snapshot
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
inferredcites →https://doi.org/10.1038/s41569-020-0360-5openalex-snapshot
COVID-19 and the cardiovascular system
inferredcites →https://doi.org/10.1038/s41586-020-2521-4openalex-snapshot
Factors associated with COVID-19-related death using OpenSAFELY
inferredcites →https://doi.org/10.1056/nejme2012924openalex-snapshot
Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
inferredcites →https://doi.org/10.1056/nejmoa2002032openalex-snapshot
Clinical Characteristics of Coronavirus Disease 2019 in China
inferredcites →https://doi.org/10.1056/nejmoa2006923openalex-snapshot
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
inferredcites →https://doi.org/10.1056/nejmoa2007621openalex-snapshot
RETRACTED: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
inferredcites →https://doi.org/10.1056/nejmoa2008975openalex-snapshot
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
inferredcites →https://doi.org/10.1056/nejmsr2005760openalex-snapshot
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
inferredcites →https://doi.org/10.1093/ajh/hpu086openalex-snapshot
Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
inferredcites →https://doi.org/10.1093/eurheartj/ehaa235openalex-snapshot
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
inferredcites →https://doi.org/10.1093/eurheartj/ehaa335openalex-snapshot
Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence
inferredcites →https://doi.org/10.1097/00004872-199606000-00017openalex-snapshot
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension
inferredcites →https://doi.org/10.1097/hjh.0000000000002450openalex-snapshot
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
inferredcites →https://doi.org/10.1111/all.14238openalex-snapshot
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
inferredcites →https://doi.org/10.1136/bmj.m1198openalex-snapshot
Covid-19: risk factors for severe disease and death
inferredcites →https://doi.org/10.1136/bmj.m1313openalex-snapshot
Drugs and the renin-angiotensin system in covid-19
inferredcites →https://doi.org/10.1152/ajpcell.00145.2008openalex-snapshot
MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides
inferredcites →https://doi.org/10.1152/ajpheart.00068.2005openalex-snapshot
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1–7) expression in the aorta of spontaneously hypertensive rats
inferredcites →https://doi.org/10.1152/ajprenal.90488.2008openalex-snapshot
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan
inferredcites →https://doi.org/10.1161/01.cir.0000094734.67990.99openalex-snapshot
Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles
inferredcites →https://doi.org/10.1161/01.hyp.0000124667.34652.1aopenalex-snapshot
Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors
inferredcites →https://doi.org/10.1161/circresaha.120.317134openalex-snapshot
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
inferredcites →https://doi.org/10.1161/circulationaha.104.510461openalex-snapshot
Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2
inferredcites →https://doi.org/10.1161/hypertensionaha.120.15082openalex-snapshot
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
inferredcites →https://doi.org/10.2807/1560-7917.es.2020.25.3.2000045openalex-snapshot
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3684465openalex-extracted
RAAS Blockers and Region-Specific Variations in COVID-19 Outcomes: Findings from a Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1001/jama.2020.25864openalex-snapshot
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.3594openalex-snapshot
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
inferred← citeshttps://doi.org/10.1002/14651858.cd013879openalex-snapshot
COVID-19 and its cardiovascular effects: a systematic review of prevalence studies
inferred← citeshttps://doi.org/10.1002/jmv.26347openalex-snapshot
Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID‐19 patients
inferred← citeshttps://doi.org/10.1002/prp2.666openalex-snapshot
A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
inferred← citeshttps://doi.org/10.1007/s11739-021-02804-xopenalex-snapshot
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s11739-022-02929-7openalex-snapshot
Renin–angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study
inferred← citeshttps://doi.org/10.1007/s11906-022-01207-3openalex-snapshot
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
inferred← citeshttps://doi.org/10.1007/s40292-021-00462-wopenalex-snapshot
Safety and Efficacy of Renin–Angiotensin–Aldosterone System Inhibitors in COVID-19 Population
inferred← citeshttps://doi.org/10.1007/s42000-020-00259-xopenalex-snapshot
The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates
inferred← citeshttps://doi.org/10.1016/j.ahj.2022.04.001openalex-snapshot
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial
inferred← citeshttps://doi.org/10.1016/j.ajem.2020.10.022openalex-snapshot
Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.arcmed.2020.12.002openalex-snapshot
Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico
inferred← citeshttps://doi.org/10.1016/j.arcmed.2021.05.003openalex-snapshot
Is Cancer an Independent Risk Factor for Fatal Outcomes of Coronavirus Disease 2019 Patients?
inferred← citeshttps://doi.org/10.1016/j.bbi.2021.01.039openalex-snapshot
Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs
inferred← citeshttps://doi.org/10.1016/j.cjco.2021.03.001openalex-snapshot
Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors
inferred← citeshttps://doi.org/10.1016/j.cmpb.2021.105951openalex-snapshot
Prediction of death status on the course of treatment in SARS-COV-2 patients with deep learning and machine learning methods
inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.100789openalex-snapshot
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107082openalex-snapshot
Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115192openalex-snapshot
Role of the renin-angiotensin-aldosterone system in sepsis and its therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.jbior.2020.100736openalex-snapshot
SARS-CoV-2 pandemic: An overview
inferred← citeshttps://doi.org/10.1016/j.jjcc.2020.10.015openalex-snapshot
Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2020.107750openalex-snapshot
A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor
inferred← citeshttps://doi.org/10.1016/s0140-6736(22)00470-6openalex-snapshot
Chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1038/s41598-022-09845-yopenalex-snapshot
Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis
inferred← citeshttps://doi.org/10.1038/s41598-022-23553-7openalex-snapshot
Developing and validating a machine learning prognostic model for alerting to imminent deterioration of hospitalized patients with COVID-19
inferred← citeshttps://doi.org/10.1089/vbz.2021.0016openalex-snapshot
Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico
inferred← citeshttps://doi.org/10.1093/cid/ciaa1592openalex-snapshot
The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1097/hjh.0000000000002658openalex-snapshot
Association between renin–angiotensin–aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment
inferred← citeshttps://doi.org/10.1097/hjh.0000000000002666openalex-snapshot
Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension
inferred← citeshttps://doi.org/10.1097/hjh.0000000000002784openalex-snapshot
Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies
inferred← citeshttps://doi.org/10.1097/j.pbj.0000000000000085openalex-snapshot
Mortality and use of angiotensin-converting enzyme inhibitors in COVID 19 disease: a systematic review
inferred← citeshttps://doi.org/10.1101/2020.06.03.20120261openalex-snapshot
Association Between ACEIs or ARBs Use and Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1101/2020.10.03.20206375openalex-snapshot
Renin Angiotensin System Inhibition and Susceptibility and Outcomes from COVID-19: A Systematic Review and Meta-analysis of 69,200 COVID-19 Patients
inferred← citeshttps://doi.org/10.1101/2021.04.23.21256014openalex-snapshot
Risk factors associated with severe outcomes of COVID-19: A systematic rapid review to inform national guidance on vaccine prioritization in Canada
inferred← citeshttps://doi.org/10.1101/2021.09.14.21263153openalex-snapshot
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)
inferred← citeshttps://doi.org/10.1101/2022.03.24.22272870openalex-snapshot
Prognostic factors for mortality, ICU and hospital admission due to SARS-CoV-2: A systematic review and meta-analysis of cohort studies in Europe
inferred← citeshttps://doi.org/10.1111/bcp.14660openalex-snapshot
Comparison of infection risks and clinical outcomes in patients with and without SARS‐CoV‐2 lung infection under renin–angiotensin–aldosterone system blockade: Systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1111/jcpt.13246openalex-snapshot
Use of inhibitors of the renin‐angiotensin system in hypertensive patients and COVID‐19 severity: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1136/heartjnl-2020-317336openalex-snapshot
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
inferred← citeshttps://doi.org/10.1155/2022/8698825openalex-snapshot
Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System
inferred← citeshttps://doi.org/10.1161/jaha.120.021154openalex-snapshot
Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
inferred← citeshttps://doi.org/10.1161/jaha.122.025289openalex-snapshot
Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
inferred← citeshttps://doi.org/10.1177/20420986211011345openalex-snapshot
Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1183/16000617.0098-2022openalex-snapshot
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe
inferred← citeshttps://doi.org/10.1183/23120541.00306-2020openalex-snapshot
Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance
inferred← citeshttps://doi.org/10.1186/s12879-021-06088-6openalex-snapshot
Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
inferred← citeshttps://doi.org/10.1186/s12889-021-11051-wopenalex-snapshot
A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
inferred← citeshttps://doi.org/10.1186/s40249-024-01263-8openalex-snapshot
Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review
inferred← citeshttps://doi.org/10.1371/journal.pone.0248652openalex-snapshot
The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension
inferred← citeshttps://doi.org/10.1371/journal.pone.0276774openalex-snapshot
Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.15344/2456-8171/2020/155openalex-snapshot
A Case Study: Low-carb, High-fat (LCHF) Diet Combined with Fried Food in Patient with Type 2 Diabetes and Central Obesity Reduces Need for Exogenous Insulin Injection
inferred← citeshttps://doi.org/10.15690/vramn1505openalex-snapshot
Characteristics of the COVID-19 Epidemiological Situation in the Russian Federation in 2020
inferred← citeshttps://doi.org/10.18621/eurj.886378openalex-snapshot
Presenting characteristics, comorbidities, and outcomes among 390 patients hospitalized with COVID-19 pneumonia in a tertiary hospital
inferred← citeshttps://doi.org/10.22487/j24428744.2023.v9.i2.15989openalex-snapshot
COVID-19 and Diabetes Mellitus at RSU South Tangerang-Indonesia: Clinical Profile and Treatment Strategies
inferred← citeshttps://doi.org/10.25040/lkv2024.02.014openalex-snapshot
Analysis of the Influence of Comorbid States on COVID-19 Severity and In-Hospital Mortality for Further Application in an Outpatient Setting
inferred← citeshttps://doi.org/10.3329/brc.v9i1.63598openalex-snapshot
THE RELATIONSHIP BETWEEN COVID-19 SEVERITY AND THE USAGE OF ANGIOTENSIN-II RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS
inferred← citeshttps://doi.org/10.3389/fcvm.2021.609857openalex-snapshot
Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
inferred← citeshttps://doi.org/10.3389/fmed.2021.703661openalex-snapshot
Mortality and Severity in COVID-19 Patients on ACEIs and ARBs—A Systematic Review, Meta-Analysis, and Meta-Regression Analysis
inferred← citeshttps://doi.org/10.3389/fphys.2021.624052openalex-snapshot
Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.3389/fpsyg.2021.633765openalex-snapshot
Association of Stress-Related Factors With Anxiety Among Chinese Pregnant Participants in an Online Crisis Intervention During COVID-19 Epidemic
inferred← citeshttps://doi.org/10.3389/fpubh.2022.884121openalex-snapshot
Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study
inferred← citeshttps://doi.org/10.3390/ijerph20105799openalex-snapshot
Retrospective Analysis of the Outcome of Hospitalized COVID-19 Patients with Coexisting Metabolic Syndrome and HIV Using Multinomial Logistic Regression
inferred← citeshttps://doi.org/10.3390/jcm10143147openalex-snapshot
Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis
inferred← citeshttps://doi.org/10.3390/jcm10225224openalex-snapshot
Low eGFR Is a Strong Predictor of Worse Outcome in Hospitalized COVID-19 Patients
inferred← citeshttps://doi.org/10.3390/jcm9082368openalex-snapshot
The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases
inferred← citeshttps://doi.org/10.3390/pathogens11050563openalex-snapshot
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3390/v15091794openalex-snapshot
Predictors of SARS-CoV-2 Infection and Severe and Lethal COVID-19 after Three Years of Follow-Up: A Population-Wide Study
inferred← citeshttps://doi.org/10.3390/vaccines10050662openalex-snapshot
Effectiveness of COVID-19 Vaccines in the General Population of an Italian Region before and during the Omicron Wave
inferred← citeshttps://doi.org/10.3390/vaccines11010031openalex-snapshot
COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province
inferred← citeshttps://doi.org/10.3390/vaccines11081325openalex-snapshot
COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up
inferred← citeshttps://doi.org/10.3390/vaccines9060628openalex-snapshot
Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province
inferred← citeshttps://doi.org/10.3961/jpmph.20.186openalex-snapshot
Association of Comorbidities With Pneumonia and Death Among COVID-19 Patients in Mexico: A Nationwide Cross-sectional Study
inferred← citeshttps://doi.org/10.4103/jncd.jncd_7_21openalex-snapshot
Impact of chronic obstructive pulmonary disease on severity and outcomes in COVID-19 patients
inferred← citeshttps://doi.org/10.4314/rejhs.v11i4.2openalex-snapshot
Kidney dysfunction and mortality risk in hospitalized Covid-19 patients: A large Covid-19 centre experience
inferred← citeshttps://doi.org/10.4414/smw.2021.w30105openalex-snapshot
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)
inferred← citeshttps://doi.org/10.46810/tdfd.1110094openalex-snapshot
Prediction of Epidemic Disease Severity and the Relative Importance of the Factors for Epidemic Disease Using the Machine Learning Methods
inferred← citeshttps://doi.org/10.47611/jsr.v10i4.1401openalex-snapshot
RAAS inhibitors for hypertensive patients during Covid-19 infection – a metanalysis
inferred← citeshttps://doi.org/10.57187/smw.2023.40068openalex-snapshot
Burden of disease in patients hospitalised with COVID-19 during the first and second pandemic wave in Switzerland: a nationwide cohort study
inferred← citeshttps://doi.org/10.6061/clinics/2021/e2342openalex-snapshot
Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
inferred← citeshttps://doi.org/10.6084/m9.figshare.14738369openalex-snapshot
Additional file 1 of Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
inferred← citeshttps://doi.org/10.6084/m9.figshare.15153919openalex-snapshot
Additional file 1 of A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
inferred← citeshttps://doi.org/10.7150/ijbs.54055openalex-snapshot
Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19
inferred← citeshttps://doi.org/10.7326/l20-0887openalex-snapshot
Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
inferred← citeshttps://doi.org/10.7326/l20-0969openalex-snapshot
Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
inferred← citeshttps://doi.org/10.7326/l20-1446openalex-snapshot
Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.